Over a mean follow-up of 17 years, women who used oral contraceptives before MS was diagnosed had a 26% lower risk of PIRA ...

Among the 13 CAR-T therapeutics that have received regulatory approval are Gilead’s Yescarta and Immuneel Therapeutics’ ...

In red and white until last year, the midfielder has great expectations for Sunday's derby: "A prediction? I really don't ...

Older patients and those with genetic risk factors were at particularly high risk of relapse and had poorer overall survival.

Chugai introduces Lunsumio for intravenous infusion, a bispecific antibody to treat relapsed or refractory follicular lymphoma in Japan: Tokyo Thursday, March 20, 2025, 11:00 Hrs ...

DelveInsight's "CABLIVI Market Size, Forecast, and Market Insight Report" highlights the details around CABLIVI, a von ...

Reality TV star Rick Harrison sat down for an interview to discuss the challenges he has faced over the past year since his son's passing.

The head coach has urged his players to put "another star on the jersey" with World Cup glory, and here's who he should ...

Developed by Sanofi, CABLIVI is the first FDA-approved nanobody therapy for this condition. Increasing awareness, improved diagnostic rates, and rising demand for targeted therapies in hematology ...